Sales rise 4.03% to Rs 223.86 crore
Net profit of Astrazeneca Pharma India declined 8.22% to Rs 26.70 crore in the quarter ended December 2019 as against Rs 29.09 crore during the previous quarter ended December 2018. Sales rose 4.03% to Rs 223.86 crore in the quarter ended December 2019 as against Rs 215.19 crore during the previous quarter ended December 2018. ParticularsQuarter EndedDec. 2019Dec. 2018% Var.Sales223.86215.19 4 OPM %16.4218.99 -PBDT39.9544.37 -10 PBT35.1840.59 -13 NP26.7029.09 -8Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
